The test uses swabs from patients with rash symptoms and is processed at Quest’s lab in San Juan Capistrano, Calif., the company said July 13. By the end of July, Quest expects to be able to perform 30,000 per week.
The lab said it plans to launch the CDC’s orthopoxvirus test in August.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.